Help Ensure Safe Dispensing of Diabetes Meds
March 2025
You’ll see more patients getting an SGLT2 inhibitor (canagliflozin, etc) or GLP-1 agonist (semaglutide, etc) first-line for type 2 diabetes.
Metformin will still be the gold standard for most patients...because of its established efficacy, safety, and low cost.
But certain patients will now start with an SGLT2 inhibitor or GLP-1 agonist instead...since these meds also have heart or kidney benefits.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote